This content is machine translated Hematologic malignancies Lymphocytic lymphomas and leukemias: focus on current therapies Malignant hematologic diseases such as leukemias or lymphomas represent the fourth most common cancer and affect approximately 20/100,000 population per year in Europe. A number of effective substances are now…
